4/A

FORM 4/A SUBMISSION

Company: ALNYLAM PHARMACEUTICALS, INC.
Filed: October 28, 2014
Period of Report: October 22, 2014
Accession Number: 0001209191-14-065101

View Document ↗ View on SEC.gov ↗